Sex Differences in Smoking Cessation Pharmacotherapy Comparative Efficacy: A Network Meta-analysis
Philip H Smith1,2,3, Andrea H Weinberger4,5, Ju Zhang6
1Community Health and Social Medicine, Sophie Davis School of Biomedical Education/CUNY School of Medicine, New York, NY.
Varenicline is more effective for women than men in smoking cessation compared to nicotine patches and bupropion. Clinicians should consider varenicline as a first-line treatment for women seeking to quit smoking.
Area of Science:
- Pharmacology
- Addiction Medicine
- Public Health
Background:
- Sex-specific differences in treatment efficacy are increasingly recognized in pharmacological interventions.
- Smoking cessation pharmacotherapy efficacy may vary between men and women.
Purpose of the Study:
- To compare the efficacy of transdermal nicotine (TN), varenicline, and sustained-release (SR) bupropion for smoking cessation.
- To investigate potential sex differences in the comparative effectiveness of these smoking cessation medications.
Main Methods:
- Network meta-analyses of randomized, double-blind, placebo-controlled trials.
- Inclusion of studies on bupropion-SR, TN, and varenicline for smoking cessation.
- Analysis of data from 14,389 smokers, with 51% being female.
Main Results:
- Varenicline demonstrated greater efficacy than TN and bupropion for women.
- For men, varenicline showed similar outcomes compared to TN and bupropion.
- All tested medications improved quit rates compared to placebo for both sexes.
Conclusions:
- Varenicline offers a significant advantage over bupropion SR and TN for women's smoking cessation.
- Varenicline is recommended as a first-line treatment option for women.
- The comparative advantage of varenicline over TN or bupropion is less pronounced in men.
More Related Videos
10:44Comparing the Effects of Electronic Cigarette Vapor and Cigarette Smoke in a Novel In Vivo Exposure System
Published on: May 24, 2017
09:50Impact Assessment of Repeated Exposure of Organotypic 3D Bronchial and Nasal Tissue Culture Models to Whole Cigarette Smoke
Published on: February 12, 2015
Related Concept Videos
Statistical Methods for Analyzing Epidemiological Data
Drugs Acting on Autonomic Ganglia: Stimulants
Ganglionic stimulants activate NM nicotinic receptors in autonomic ganglia, falling into two categories: nicotine mimetics [e.g., lobeline, dimethylpiperazine, tetramethylammonium] and muscarinic receptor agonists [e.g., muscarine, methacholine]. The first category's action is rapid and blocked by nicotinic receptor antagonists, while the second category's action is delayed and blocked by atropine-like agents. Nicotine, an alkaloid, affects the heart rate by stimulating...
Dose-Response Relationship: Potency and Efficacy
Antidepressant Drugs: MAOIs and Other Agents
Combined Effects of Drugs: Antagonism
The most common type is receptor antagonism, where one drug acts as an antagonist to block the effects of another drug by...
Drug Dependence
